Sanofi-Synthelabo to acquire Keunwha Pharm in 90.0 billion deal

Published: 2002-08-06 06:59:00

Updated: 2002-08-06 06:59:00

Sanofi-Synthelabo Korea affiliated with the world's largest drug company, Paris-based Sanofi-Synthelabo of France, said on July 29 it signed an agreement with Keunwha Pharm in a bid to acquire the latter's pharmaceutical division.

Under the definitive agreement, Sanofi-Synthelabo Korea will bu...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK